Evidence map›Paper›PMID 27363681›Full record

ArticleScientific reports2016

Involvement of the pagR gene of pXO2 in anthrax pathogenesis.

Xudong Liang, Enmin Zhang, Huijuan Zhang, Jianchun Wei, Wei Li, Jin Zhu, Bingxiang Wang, Shulin Dong

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Genes · 2023
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Xudong LiangNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control, 102206, Beijing, China.
Enmin ZhangNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control, 102206, Beijing, China.
Huijuan ZhangNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control, 102206, Beijing, China.
Jianchun WeiNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control, 102206, Beijing, China.
Wei LiNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control, 102206, Beijing, China.
Jin ZhuHuadong Medical Institute of Biotechniques, 210002, Nanjing, China.
Bingxiang WangLanzhou Institute of Biological Products Co. Ltd, 730046, Lanzhou, China.
Shulin DongLanzhou Institute of Biological Products Co. Ltd, 730046, Lanzhou, China.
National Institute for Communicable Disease Control and Prevention · CNLanzhou Institute of Husbandry and Pharmaceutical Sciences · CNHuadong Hospital · CNState Key Laboratory of Infectious Disease Prevention and Control

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthrax is a disease caused by Bacillus anthracis. Specifically, the anthrax toxins and capsules encoded by the pXO1 and pXO2 plasmids, respectively, are the major virulence factors. We previously reported that the pXO1 plasmid was retained in the attenuated strain of B. anthracis vaccine strains even after subculturing at high temperatures. In the present study, we reinvestigate the attenuation mechanism of Pasteur II. Sequencing of pXO1 and pXO2 from Pasteur II strain revealed mutations in these plasmids as compared to the reference sequences. Two deletions on these plasmids, one each on pXO1 and pXO2, were confirmed to be unique to the Pasteur II strain as compared to the wild-type strains. Gene replacement with homologous recombination revealed that the mutation in the promoter region of the pagR gene on pXO2, but not the mutation on pXO1, contributes to lethal levels of toxin production. This result was further confirmed by RT-PCR, western blot, and animal toxicity assays. Taken together, our results signify that the attenuation of the Pasteur II vaccine strain is caused by a mutation in the pagR gene on its pXO2 plasmid. Moreover, these data suggest that pXO2 plasmid encoded proteins are involved in the virulence of B. anthracis.

Indexed as

AnimalsAnthraxAntigens, BacterialBacillus anthracisBacterial ProteinsBacterial ToxinsBase SequenceDNA, BacterialMaleMice, Inbred BALB CMutationPlasmidsPromoter Regions, GeneticRepressor ProteinsSequence Analysis, DNASurvival Analysisanthrax toxinAntigens, BacterialBacterial ProteinsBacterial ToxinsDNA, BacterialPagR protein, Bacillus anthracisRepressor Proteins

Identifiers

PMID27363681
PMCPMC4929452
OpenAlexW2464225082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.